Wipro's MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions
The US Generics market has been witnessing significant pricing pressure leading to significant losses at Jubilant Cadista since FY2022 onwards.
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
The survey data presented in “The State of the Biopharmaceutical Industry 2024” report reveals that N=21 (18%) of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year
Currently, Venkat is Lead – Market Access, India at Pfizer
US business grew by +12.8% YoY
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The company has entered into a three-year Deferred Prosecution Agreement
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Subscribe To Our Newsletter & Stay Updated
